RTOG 0227: Phase I/II study of pre-irradiation chemotherapy with methotrexate, rituximab, and temozolomide and post-irradiation temozolomide for primary central nervous system lymphoma Conference

Glass, Jon, Berkey, Brian A, Schultz, Christopher et al. (2006). RTOG 0227: Phase I/II study of pre-irradiation chemotherapy with methotrexate, rituximab, and temozolomide and post-irradiation temozolomide for primary central nervous system lymphoma . NEURO-ONCOLOGY, 8(4), 443-443.

cited authors

  • Glass, Jon; Berkey, Brian A; Schultz, Christopher; Brat, Daniel J; Bartlett, Nancy L; Brown, Paul; Gore, Elizabeth; Sperduto, Paul; Mehta, Minesh

authors

date/time interval

  • September 14, 2006 -

publication date

  • October 1, 2006

webpage

published in

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

Location

  • Vienna, AUSTRIA

Conference

  • 7th Congress of the European-Association-for-Neuro-Oncology (EANO)

publisher

  • OXFORD UNIV PRESS INC

start page

  • 443

end page

  • 443

volume

  • 8

issue

  • 4